-
Exosomes 101 - Exosome Engineering
The ultimate nanovehicle - engineer exosomes for custom cargo delivery shuttles into target cells. Cargoes include nucleic acid and even small molecules. Continue reading → -
Exosomes 101 - Exosome Characterization and Discovery
Present in a wide variety of body fluids - including the easily accessible urine, plasma, and saliva - and loaded with cargoes of general and unique nucleic acid, protein, and lipids, exosomes provide an exciting opportunity for the discovery of disease biomarkers. Continue reading → -
Exosomes 101 - Exosome Detection & Characterization
A number of different biochemical and biophysical techniques can be used to verify that your preparation contains exosomes, and to quantify the amount of exosomes you have isolated. Continue reading → -
RESEARCH HIGHLIGHT: Identifying miR-3662 as a new player in hematopoiesis and acute myeloid leukemia (AML)
SBI’s lentiviral reagents and miR services help researchers bridge the gap between GWAS and phenotype at a QTL involved in hematopoiesis and acute myeloid leukemia. Continue reading → -
System Biosciences Announces License of ExoQuick® Technology to QIAGEN
PRESS RELEASE: System Biosciences (SBI), a leading provider of exosome research tools and services, Continue reading → -
What’s new in exosome research? Here are a few of the recent papers we’re most excited about
A roundup of the recent exosome literature highlights the therapeutic potential of stem cell-derived exosomes and the complex role of exosomes in cancer. Continue reading → -
Did you know? SBI offers exosome education opportunities, both hands-on and custom seminars
SBI offers hands-on and custom on-line/in-person opportunities to learn more about exosomes and stay up-to-date with the latest advances. Continue reading → -
RESEARCH HIGHLIGHT: Are extracellular vesicles playing a role in invasiveness and therapy resistance in glioblastoma? This paper argues yes.
SBI’s Exo-NGS Service drives discoveries and fuels insights into glioblastoma heterogeneity and, thus, pathogenicity. Continue reading → -
RESEARCH HIGHLIGHT: Revisiting old antiviral strategies in better, safer ways to fight emerging viruses like Zika, Chikungunya, and Dengue
System Biosciences pGreenFire Reporter Vectors fuel antiviral drug discovery and the search for robust, broad-spectrum antiviral agents. Continue reading → -
Did you know? You can commercialize your technology with SBI
SBI works with scientists to commercialize their technologies through licensing and other programs. Continue reading →
Page
- Page Previous
- Page 1
- You're currently reading page 2
- Page 3
- Page Next